Acelyrin (SLRN) Institutional Ownership → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free SLRN Stock Alerts $4.35 -0.04 (-0.91%) (As of 03:10 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Acelyrin (NASDAQ:SLRN)CurrentInstitutional OwnershipPercentage87.31%Number ofInstitutional Buyers(last 12 months)58TotalInstitutional Inflows(last 12 months)$659.32MNumber ofInstitutional Sellers(last 12 months)15TotalInstitutional Outflows(last 12 months)$33.63M Get SLRN Insider Trade Alerts Want to know when executives and insiders are buying or selling Acelyrin stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SLRN Institutional Buying and Selling by Quarter Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. Acelyrin Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 Artal Group S.A.2,405,143$16.24M0.4%-20.8%2.429% 5/17/2024 Ikarian Capital LLC1,564,340$10.56M1.2%-32.8%1.580% 5/16/2024 California State Teachers Retirement System7,301$49K0.0%-67.9%0.007% 5/16/2024 Jacobs Levy Equity Management Inc.586,746$3.96M0.0%N/A0.593% 5/16/2024 Kennedy Capital Management LLC486,560$3.28M0.1%+2.6%0.492% 5/16/2024 Kynam Capital Management LP396,379$2.68M0.3%-67.0%0.401% Get the Latest News and Ratings for SLRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acelyrin and its competitors with MarketBeat's FREE daily newsletter. 5/15/2024 Public Employees Retirement System of Ohio28,418$192K0.0%N/A0.029% 5/15/2024 Price T Rowe Associates Inc. MD20,703$140K0.0%N/A0.021% 5/14/2024 EntryPoint Capital LLC11,033$74K0.1%-47.4%0.011% 5/14/2024 StemPoint Capital LP714,773$4.83M1.3%+21.7%0.723% 5/14/2024 American International Group Inc.35,793$242K0.0%+117.3%0.036% 5/13/2024 Ameritas Investment Partners Inc.7,243$49K0.0%+118.0%0.007% 5/10/2024 Vanguard Group Inc.6,237,543$42.10M0.0%+1.3%6.306% 5/9/2024 Blair William & Co. IL138,595$936K0.0%N/A0.140% 5/8/2024 ProShare Advisors LLC19,871$134K0.0%+69.9%0.020% 5/8/2024 Russell Investments Group Ltd.27,108$183K0.0%N/A0.027% 4/29/2024 China Universal Asset Management Co. Ltd.18,718$126K0.0%+66.2%0.019% 2/14/2024 Point72 Europe London LLP122,971$917K0.1%N/A0.126% 2/14/2024 Superstring Capital Management LP356,924$2.66M1.9%N/A0.367% 2/14/2024 Lighthouse Investment Partners LLC86,651$646K0.0%N/A0.089% 2/14/2024 Sectoral Asset Management Inc.325,549$2.43M1.0%N/A0.334% 2/12/2024 Capstone Investment Advisors LLC27,345$204K0.0%N/A0.028% 2/12/2024 Decheng Capital LLC1,370,951$10.23M2.9%N/A1.408% 2/9/2024 Dynamic Technology Lab Private Ltd14,431$108K0.0%N/A0.015% 2/7/2024 Jump Financial LLC49,500$369K0.0%+152.7%0.051% 2/6/2024 Swiss National Bank38,300$286K0.0%-40.2%0.039% 2/1/2024 New York State Common Retirement Fund13,181$98K0.0%+84.4%0.014% 1/30/2024 Zurcher Kantonalbank Zurich Cantonalbank10,716$80K0.0%+608.3%0.011% 1/30/2024 Strs Ohio42,300$315K0.0%+504.3%0.043% 1/30/2024 Vontobel Holding Ltd.325,549$2.43M0.0%N/A0.334% 1/24/2024 Mirae Asset Global Investments Co. Ltd.17,038$127K0.0%-15.6%0.018% 1/24/2024 China Universal Asset Management Co. Ltd.11,259$84K0.0%N/A0.012% 1/16/2024 Raymond James & Associates10,522$78K0.0%-43.3%0.011% 1/12/2024 SG Americas Securities LLC14,741$110K0.0%N/A0.015% 12/18/2023 Vanguard Group Inc.3,189,027$32.43M0.0%+3.8%3.276% 12/6/2023 Citigroup Inc.73,269$745K0.0%N/A0.075% 11/29/2023Decheng Capital Management III Cayman LLC1,548,317$15.75M4.0%-0.4%1.591% 11/21/2023 Walleye Capital LLC447,355$4.55M0.0%N/A0.460% 11/15/2023 Kynam Capital Management LP1,200,000$12.20M2.0%N/A1.233% 11/15/2023 Adage Capital Partners GP L.L.C.100,000$1.02M0.0%-73.0%0.103% **Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!Click for Zack's full report11/14/2023 venBio Partners LLC3,852,470$39.18M11.1%-0.1%3.962% 11/14/2023 Schonfeld Strategic Advisors LLC202,662$2.06M0.0%+267.1%0.208% 11/14/2023 Fred Alger Management LLC53,206$541K0.0%-94.7%0.055% 11/14/2023 Profund Advisors LLC29,232$297K0.0%N/A0.030% 11/13/2023 Eagle Asset Management Inc.358,363$3.65M0.0%-31.1%0.369% 11/13/2023CHI Advisors LLC2,262,990$23.02M6.9%-15.0%2.327% 11/13/2023 FMR LLC8,961,726$89.91M0.0%+20.2%9.216% 11/13/2023 Rafferty Asset Management LLC173,696$1.77M0.0%N/A0.179% 11/9/2023 Citigroup Inc.73,269$745K0.0%N/A0.075% 11/8/2023 Ausdal Financial Partners Inc.21,000$214K0.0%N/A0.022% 11/8/2023 Swiss National Bank64,100$652K0.0%N/A0.066% 11/8/2023 Amalgamated Bank4,281$44K0.0%N/A0.004% 11/7/2023 New York State Common Retirement Fund7,149$73K0.0%N/A0.007% 11/7/2023 Barclays PLC106,688$1.08M0.0%N/A0.110% 11/7/2023 Jump Financial LLC19,592$199K0.0%-17.3%0.020% 10/27/2023 TD Asset Management Inc75,164$764K0.0%+22.0%0.077% 10/26/2023 Mirae Asset Global Investments Co. Ltd.20,196$205K0.0%N/A0.021% 10/26/2023 Strs Ohio7,000$71K0.0%N/A0.007% 10/24/2023 Bank of New York Mellon Corp92,701$943K0.0%+601.1%0.095% 10/24/2023 Raymond James & Associates18,556$189K0.0%N/A0.019% 8/24/2023 Perceptive Advisors LLC200,000$4.18M0.1%N/A0.206% 8/22/2023CHI Advisors LLC2,663,806$55.67M16.8%N/A2.739% 8/15/2023 Braidwell LP500,000$10.45M0.3%N/A0.514% 8/14/2023 Samsara BioCapital LLC2,256,022$47.15M8.3%N/A2.321% 8/14/2023 Marshall Wace LLP1,161,528$24.28M0.0%N/A1.195% 8/14/2023 Rock Springs Capital Management LP141,876$2.97M0.1%N/A0.146% 8/14/2023 Driehaus Capital Management LLC1,758,797$36.76M0.5%N/A1.809% 8/14/2023 Ghisallo Capital Management LLC70,000$1.46M0.2%N/A0.072% 8/11/2023 AyurMaya Capital Management Company LP9,334,735$195.10M100.0%N/A9.604% 8/11/2023 General Atlantic L.P.1,500,000$31.35M0.5%N/A1.543% 8/11/2023 Sectoral Asset Management Inc.201,017$4.20M0.7%N/A0.207% 8/11/2023 Landscape Capital Management L.L.C.15,426$322K0.0%N/A0.016% 8/11/2023 Franklin Resources Inc.879,268$18.38M0.0%N/A0.905% 8/11/2023 Artal Group S.A.1,821,214$38.06M1.2%N/A1.874% 8/11/2023 JPMorgan Chase & Co.3,703,338$77.40M0.0%N/A3.810% 8/11/2023 ExodusPoint Capital Management LP111,077$2.32M0.0%N/A0.114% 8/9/2023 TD Asset Management Inc61,610$1.29M0.0%N/A0.063% 8/3/2023 Jennison Associates LLC200,000$4.18M0.0%N/A0.206% 8/2/2023 Bank of Montreal Can93,315$1.85M0.0%N/A0.096% 7/28/2023Decheng Capital Management III Cayman LLC1,554,417$32.49M10.2%N/A1.599% (Data available from 1/1/2016 forward) SLRN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SLRN shares? During the previous two years, 65 institutional investors and hedge funds held shares of Acelyrin. The most heavily invested institutionals were AyurMaya Capital Management Company LP ($195.10M), FMR LLC ($89.91M), JPMorgan Chase & Co. ($77.40M), Samsara BioCapital LLC ($47.15M), Vanguard Group Inc. ($42.10M), venBio Partners LLC ($39.18M), and Driehaus Capital Management LLC ($36.76M).Learn more on SLRN's institutional investors. What percentage of Acelyrin stock is owned by institutional investors? 87.31% of Acelyrin stock is owned by institutional investors. Learn more on SLRN's institutional investor holdings. Which institutional investors have been buying Acelyrin stock? Of the 58 institutional investors that purchased Acelyrin stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AyurMaya Capital Management Company LP ($9.33M), JPMorgan Chase & Co. ($3.70M), CHI Advisors LLC ($2.66M), Samsara BioCapital LLC ($2.26M), Artal Group S.A. ($1.82M), Driehaus Capital Management LLC ($1.76M), and Decheng Capital Management III Cayman LLC ($1.55M). How much institutional buying is happening at Acelyrin? Institutional investors have bought a total of 36,134,903 shares in the last 24 months. This purchase volume represents approximately $659.32M in transactions. Which Acelyrin major shareholders have been selling company stock? Of the 15 institutional investors that sold Acelyrin stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Fred Alger Management LLC ($956.84K), Kynam Capital Management LP ($803.62K), Ikarian Capital LLC ($763.57K), Artal Group S.A. ($630.75K), CHI Advisors LLC ($400.82K), Adage Capital Partners GP L.L.C. ($270K), and Eagle Asset Management Inc. ($161.69K). How much institutional selling is happening at Acelyrin? Institutional investors have sold a total of 4,064,601 shares in the last 24 months. This volume of shares sold represents approximately $33.63M in transactions. Related Companies: MREO Major Shareholders LXRX Major Shareholders TBPH Major Shareholders PEPG Major Shareholders LRMR Major Shareholders BMEA Major Shareholders NGNE Major Shareholders FULC Major Shareholders OCS Major Shareholders HRTX Major Shareholders This page (NASDAQ:SLRN) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldUrgent Nvidia WarningAltimetryThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acelyrin, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.